Daniel Streetman, manager of referential content in the Metabolism, Interactions, & Genomics group with Clinical Effectiveness at Wolters Kluwer, discusses the potential for pharmacogenomics to transform prescribed drugs and reduce instances of adverse drug reactions.
Connected health
Prescribing the correct drug to a patient at the correct dosage is one of the most common daily challenges faced by clinicians, especially when the drug triggers an unexpected side effect.
There are a variety of reasons why drug treatments might not work as anticipated, including the patient’s genetic profile. This is why more work is now taking place to understand the complex relationship between the genome and drug response, in the fast-growing field of pharmacogenomics.